Industry bodies inform regulatory body review process, involving the FDA and the American Society of Clinical Oncology.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Industry bodies inform regulatory body review process, involving the FDA and the American Society of Clinical Oncology.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
American Society of Clinical Oncology
organization
Nothing else this week.
Related events
- Industry trends are influenced by regulatory body requests, according to a recent report involving RTI International.
- The FDA is reviewing drug data and company resubmissions, while also overseeing the functions of the U.S. Department of Health and Human Services.
- FDA reviewed protocol amendment and interim safety data for a company's product.
- Both the FDA and the European Medicines Agency govern drug approval processes.
- FDA guidance changes affect biosimilar approval, impacting Coherus Oncology, Inc.